• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

cvrx

FDA approves magnetic resonance labeling for CVRx’s Barostim neuromodulation system

May 9, 2022 By Sean Whooley

CVRx (Nasdaq:CVRX) announced today that the FDA approved magnetic resonance (MR) conditional labeling for its Barostim system. The Barostim neuromodulation system for treating the symptoms of heart failure now includes instructions to allow for safe MRI scans of the head and lower extremities, offering heart failure patients implanted with Barostim more diagnostic options. Minneapolis-based CVRx […]

Filed Under: Cardiovascular, Featured, Food & Drug Administration (FDA), Imaging, Implants, Neurological, Neuromodulation/Neurostimulation, News Well, Regulatory/Compliance Tagged With: cvrx, CVRx Inc., FDA

CVRx misses in Q4, wins FDA approval for new IPG

February 15, 2022 By Jim Hammerand

CVRx (NSDQ:CVRX) posted fourth-quarter results today that fell short of the consensus forecast on Wall Street and offered its outlook for the year ahead. The Brooklyn Park, Minnesota–based neuromodulation implant developer reported a loss of $10.57 million, or $0.52 per diluted share, on sales of $3.7 million for the three months ended Dec. 31, 2021, […]

Filed Under: Blog, Business/Financial News, Cardiac Implants, Cardiovascular, Featured, Implants, MassDevice Earnings Roundup, News Well Tagged With: cvrx

The 18 most innovative medical devices of 2021

July 20, 2021 By Danielle Kirsh

The Galien Foundation today announced the nominees for most innovative medical devices for its 15th annual Prix Galien USA Awards. The foundation nominates devices, biotechnology and pharmaceutical products for its annual Prix Galien awards to highlight products designed to improve the human condition. “The Awards Committee is excited to introduce the nominees for the 2021 […]

Filed Under: Cardiac Implants, Cardiovascular, Catheters, Cosmetic/Aesthetic, Dental, Diagnostics, Digital Health, Endoscopic, Featured, Imaging, Implants, Optical/Ophthalmic, Pain Management, Patient Monitoring, Pharmaceutical, Replacement Heart Valves, Respiratory, Stents, Structural Heart, Structural Heart, Urology Tagged With: Allergan, baylismedical, BD, Biotronik, Boston Scientific, Cala Health, cvrx, Edwards Lifesciences, endomag, Galien Foundation, Glaukos, humanoptics, Pear Therapeutics, Prix Galien USA, Pulmonx, Sonendo, tevapharmaceuticals

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS